BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10464165)

  • 1. Distinctive roles of Fyn and Lyn in IgD- and IgM-mediated signaling.
    Horikawa K; Nishizumi H; Umemori H; Aizawa S; Takatsu K; Yamamoto T
    Int Immunol; 1999 Sep; 11(9):1441-9. PubMed ID: 10464165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice.
    Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Lowell CA; Tedder TF
    J Immunol; 2001 Sep; 167(5):2469-78. PubMed ID: 11509585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A computational model for early events in B cell antigen receptor signaling: analysis of the roles of Lyn and Fyn.
    Barua D; Hlavacek WS; Lipniacki T
    J Immunol; 2012 Jul; 189(2):646-58. PubMed ID: 22711887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes.
    Chan VW; Lowell CA; DeFranco AL
    Curr Biol; 1998 May; 8(10):545-53. PubMed ID: 9601638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
    Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
    J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5.
    Yasue T; Nishizumi H; Aizawa S; Yamamoto T; Miyake K; Mizoguchi C; Uehara S; Kikuchi Y; Takatsu K
    Proc Natl Acad Sci U S A; 1997 Sep; 94(19):10307-12. PubMed ID: 9294206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of src-like protooncogenes in lymphocyte proliferation.
    Yamamoto T; Yamanashi Y; Takeuchi M; Fusaki N; Uchiumi F; Katagiri T; Semba K; Toyoshima K
    Princess Takamatsu Symp; 1991; 22():293-305. PubMed ID: 1668889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulated FcepsilonRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells.
    Hernandez-Hansen V; Smith AJ; Surviladze Z; Chigaev A; Mazel T; Kalesnikoff J; Lowell CA; Krystal G; Sklar LA; Wilson BS; Oliver JM
    J Immunol; 2004 Jul; 173(1):100-12. PubMed ID: 15210764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tyrosine kinase Lyn is required for B cell development beyond the T1 stage in the spleen: rescue by over-expression of Bcl-2.
    Meade J; Fernandez C; Turner M
    Eur J Immunol; 2002 Apr; 32(4):1029-34. PubMed ID: 11920569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Signaling mutations and autoimmunity.
    Yu CC; Mamchak AA; DeFranco AL
    Curr Dir Autoimmun; 2003; 6():61-88. PubMed ID: 12408047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice.
    Wang J; Koizumi T; Watanabe T
    J Exp Med; 1996 Sep; 184(3):831-8. PubMed ID: 9064343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Independent and opposing roles for Btk and lyn in B and myeloid signaling pathways.
    Satterthwaite AB; Lowell CA; Khan WN; Sideras P; Alt FW; Witte ON
    J Exp Med; 1998 Sep; 188(5):833-44. PubMed ID: 9730885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fyn and Lyn phosphorylate the Fc receptor gamma chain downstream of glycoprotein VI in murine platelets, and Lyn regulates a novel feedback pathway.
    Quek LS; Pasquet JM; Hers I; Cornall R; Knight G; Barnes M; Hibbs ML; Dunn AR; Lowell CA; Watson SP
    Blood; 2000 Dec; 96(13):4246-53. PubMed ID: 11110698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice.
    Nishizumi H; Taniuchi I; Yamanashi Y; Kitamura D; Ilic D; Mori S; Watanabe T; Yamamoto T
    Immunity; 1995 Nov; 3(5):549-60. PubMed ID: 7584145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-linking of B cell receptor-related MB-1 molecule induces protein tyrosine phosphorylation in early B lineage cells.
    Matsuo T; Nomura J; Kuwahara K; Igarashi H; Inui S; Hamaguchi M; Kimoto M; Sakaguchi N
    J Immunol; 1993 May; 150(9):3766-75. PubMed ID: 8473731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced dosage of Bruton's tyrosine kinase uncouples B cell hyperresponsiveness from autoimmunity in lyn-/- mice.
    Whyburn LR; Halcomb KE; Contreras CM; Lowell CA; Witte ON; Satterthwaite AB
    J Immunol; 2003 Aug; 171(4):1850-8. PubMed ID: 12902486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of B cell receptor-mediated signaling in B-1 cells through CD5 and Ly49 co-receptors via Lyn kinase activity.
    Ochi H; Watanabe T
    Int Immunol; 2000 Oct; 12(10):1417-23. PubMed ID: 11007759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immature B lymphocytes are deficient in expression of the src-family kinases p59fyn and p55fgr1.
    Wechsler RJ; Monroe JG
    J Immunol; 1995 Feb; 154(4):1919-29. PubMed ID: 7836773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD19 amplification of B lymphocyte Ca2+ responses: a role for Lyn sequestration in extinguishing negative regulation.
    Fujimoto M; Poe JC; Hasegawa M; Tedder TF
    J Biol Chem; 2001 Nov; 276(48):44820-7. PubMed ID: 11584010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals.
    Nishizumi H; Horikawa K; Mlinaric-Rascan I; Yamamoto T
    J Exp Med; 1998 Apr; 187(8):1343-8. PubMed ID: 9547345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.